img

Global Naloxone Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Naloxone Market Insights, Forecast to 2034

Naloxone drug in this report.
Global Naloxone market is expected to reach to US$ 28510 million in 2024, with a positive growth of %, compared with US$ 26800 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Naloxone industry is evaluated to reach US$ 33840 million in 2029. The CAGR will be 2.9% during 2024 to 2029.
Globally, Naloxone key manufacturers include ADAPT Pharma, Amphastar Pharmaceuticals, Pfizer, Kaleo, Sandoz, Amneal Pharmaceuticals, West Ward Pharmaceuticals and Mylan, etc. ADAPT Pharma, Amphastar Pharmaceuticals, Pfizer are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Naloxone were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Naloxone market and estimated to attract more attentions from industry insiders and investors.
Naloxone can be divided into Spray Forms and Injectable Forms, etc. Spray Forms is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Naloxone is widely used in various fields, such as Drug Store, Hospital Pharmacies and Online,, etc. Drug Store provides greatest supports to the Naloxone industry development. In 2022, global % sales of Naloxone went into Drug Store filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Naloxone market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Naloxone market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


ADAPT Pharma
Amphastar Pharmaceuticals
Pfizer
Kaleo
Sandoz
Amneal Pharmaceuticals
West Ward Pharmaceuticals
Mylan
Segment by Type
Spray Forms
Injectable Forms

Segment by Application


Drug Store
Hospital Pharmacies
Online

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Naloxone plant distribution, commercial date of Naloxone, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Naloxone introduction, etc. Naloxone Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Naloxone
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Naloxone Product Introduction
1.2 Market by Type
1.2.1 Global Naloxone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Spray Forms
1.2.3 Injectable Forms
1.3 Market by Application
1.3.1 Global Naloxone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Drug Store
1.3.3 Hospital Pharmacies
1.3.4 Online
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Naloxone Sales Estimates and Forecasts 2018-2029
2.2 Global Naloxone Revenue by Region
2.2.1 Global Naloxone Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Naloxone Revenue by Region (2018-2024)
2.2.3 Global Naloxone Revenue by Region (2024-2029)
2.2.4 Global Naloxone Revenue Market Share by Region (2018-2029)
2.3 Global Naloxone Sales Estimates and Forecasts 2018-2029
2.4 Global Naloxone Sales by Region
2.4.1 Global Naloxone Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Naloxone Sales by Region (2018-2024)
2.4.3 Global Naloxone Sales by Region (2024-2029)
2.4.4 Global Naloxone Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Naloxone Sales by Manufacturers
3.1.1 Global Naloxone Sales by Manufacturers (2018-2024)
3.1.2 Global Naloxone Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Naloxone in 2022
3.2 Global Naloxone Revenue by Manufacturers
3.2.1 Global Naloxone Revenue by Manufacturers (2018-2024)
3.2.2 Global Naloxone Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Naloxone Revenue in 2022
3.3 Global Key Players of Naloxone, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Naloxone Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Naloxone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Naloxone, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Naloxone, Product Offered and Application
3.8 Global Key Manufacturers of Naloxone, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Naloxone Sales by Type
4.1.1 Global Naloxone Historical Sales by Type (2018-2024)
4.1.2 Global Naloxone Forecasted Sales by Type (2024-2029)
4.1.3 Global Naloxone Sales Market Share by Type (2018-2029)
4.2 Global Naloxone Revenue by Type
4.2.1 Global Naloxone Historical Revenue by Type (2018-2024)
4.2.2 Global Naloxone Forecasted Revenue by Type (2024-2029)
4.2.3 Global Naloxone Revenue Market Share by Type (2018-2029)
4.3 Global Naloxone Price by Type
4.3.1 Global Naloxone Price by Type (2018-2024)
4.3.2 Global Naloxone Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Naloxone Sales by Application
5.1.1 Global Naloxone Historical Sales by Application (2018-2024)
5.1.2 Global Naloxone Forecasted Sales by Application (2024-2029)
5.1.3 Global Naloxone Sales Market Share by Application (2018-2029)
5.2 Global Naloxone Revenue by Application
5.2.1 Global Naloxone Historical Revenue by Application (2018-2024)
5.2.2 Global Naloxone Forecasted Revenue by Application (2024-2029)
5.2.3 Global Naloxone Revenue Market Share by Application (2018-2029)
5.3 Global Naloxone Price by Application
5.3.1 Global Naloxone Price by Application (2018-2024)
5.3.2 Global Naloxone Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Naloxone Market Size by Type
6.1.1 US & Canada Naloxone Sales by Type (2018-2029)
6.1.2 US & Canada Naloxone Revenue by Type (2018-2029)
6.2 US & Canada Naloxone Market Size by Application
6.2.1 US & Canada Naloxone Sales by Application (2018-2029)
6.2.2 US & Canada Naloxone Revenue by Application (2018-2029)
6.3 US & Canada Naloxone Market Size by Country
6.3.1 US & Canada Naloxone Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Naloxone Sales by Country (2018-2029)
6.3.3 US & Canada Naloxone Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Naloxone Market Size by Type
7.1.1 Europe Naloxone Sales by Type (2018-2029)
7.1.2 Europe Naloxone Revenue by Type (2018-2029)
7.2 Europe Naloxone Market Size by Application
7.2.1 Europe Naloxone Sales by Application (2018-2029)
7.2.2 Europe Naloxone Revenue by Application (2018-2029)
7.3 Europe Naloxone Market Size by Country
7.3.1 Europe Naloxone Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Naloxone Sales by Country (2018-2029)
7.3.3 Europe Naloxone Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Naloxone Market Size
8.1.1 China Naloxone Sales (2018-2029)
8.1.2 China Naloxone Revenue (2018-2029)
8.2 China Naloxone Market Size by Application
8.2.1 China Naloxone Sales by Application (2018-2029)
8.2.2 China Naloxone Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Naloxone Market Size by Type
9.1.1 Asia Naloxone Sales by Type (2018-2029)
9.1.2 Asia Naloxone Revenue by Type (2018-2029)
9.2 Asia Naloxone Market Size by Application
9.2.1 Asia Naloxone Sales by Application (2018-2029)
9.2.2 Asia Naloxone Revenue by Application (2018-2029)
9.3 Asia Naloxone Sales by Region
9.3.1 Asia Naloxone Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Naloxone Revenue by Region (2018-2029)
9.3.3 Asia Naloxone Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Naloxone Market Size by Type
10.1.1 Middle East, Africa and Latin America Naloxone Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Naloxone Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Naloxone Market Size by Application
10.2.1 Middle East, Africa and Latin America Naloxone Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Naloxone Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Naloxone Sales by Country
10.3.1 Middle East, Africa and Latin America Naloxone Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Naloxone Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Naloxone Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 ADAPT Pharma
11.1.1 ADAPT Pharma Company Information
11.1.2 ADAPT Pharma Overview
11.1.3 ADAPT Pharma Naloxone Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 ADAPT Pharma Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ADAPT Pharma Recent Developments
11.2 Amphastar Pharmaceuticals
11.2.1 Amphastar Pharmaceuticals Company Information
11.2.2 Amphastar Pharmaceuticals Overview
11.2.3 Amphastar Pharmaceuticals Naloxone Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Amphastar Pharmaceuticals Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amphastar Pharmaceuticals Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Naloxone Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Pfizer Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Kaleo
11.4.1 Kaleo Company Information
11.4.2 Kaleo Overview
11.4.3 Kaleo Naloxone Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Kaleo Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kaleo Recent Developments
11.5 Sandoz
11.5.1 Sandoz Company Information
11.5.2 Sandoz Overview
11.5.3 Sandoz Naloxone Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Sandoz Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sandoz Recent Developments
11.6 Amneal Pharmaceuticals
11.6.1 Amneal Pharmaceuticals Company Information
11.6.2 Amneal Pharmaceuticals Overview
11.6.3 Amneal Pharmaceuticals Naloxone Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Amneal Pharmaceuticals Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Amneal Pharmaceuticals Recent Developments
11.7 West Ward Pharmaceuticals
11.7.1 West Ward Pharmaceuticals Company Information
11.7.2 West Ward Pharmaceuticals Overview
11.7.3 West Ward Pharmaceuticals Naloxone Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 West Ward Pharmaceuticals Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 West Ward Pharmaceuticals Recent Developments
11.8 Mylan
11.8.1 Mylan Company Information
11.8.2 Mylan Overview
11.8.3 Mylan Naloxone Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Mylan Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mylan Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Naloxone Industry Chain Analysis
12.2 Naloxone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Naloxone Production Mode & Process
12.4 Naloxone Sales and Marketing
12.4.1 Naloxone Sales Channels
12.4.2 Naloxone Distributors
12.5 Naloxone Customers
13 Market Dynamics
13.1 Naloxone Industry Trends
13.2 Naloxone Market Drivers
13.3 Naloxone Market Challenges
13.4 Naloxone Market Restraints
14 Key Findings in The Global Naloxone Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Naloxone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Spray Forms
Table 3. Major Manufacturers of Injectable Forms
Table 4. Global Naloxone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Naloxone Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Naloxone Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Naloxone Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Naloxone Revenue Market Share by Region (2018-2024)
Table 9. Global Naloxone Revenue Market Share by Region (2024-2029)
Table 10. Global Naloxone Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Naloxone Sales by Region (2018-2024) & (K Units)
Table 12. Global Naloxone Sales by Region (2024-2029) & (K Units)
Table 13. Global Naloxone Sales Market Share by Region (2018-2024)
Table 14. Global Naloxone Sales Market Share by Region (2024-2029)
Table 15. Global Naloxone Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Naloxone Sales Share by Manufacturers (2018-2024)
Table 17. Global Naloxone Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Naloxone Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Naloxone, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Naloxone Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Naloxone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Naloxone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Naloxone as of 2022)
Table 23. Global Key Manufacturers of Naloxone, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Naloxone, Product Offered and Application
Table 25. Global Key Manufacturers of Naloxone, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Naloxone Sales by Type (2018-2024) & (K Units)
Table 28. Global Naloxone Sales by Type (2024-2029) & (K Units)
Table 29. Global Naloxone Sales Share by Type (2018-2024)
Table 30. Global Naloxone Sales Share by Type (2024-2029)
Table 31. Global Naloxone Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Naloxone Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Naloxone Revenue Share by Type (2018-2024)
Table 34. Global Naloxone Revenue Share by Type (2024-2029)
Table 35. Naloxone Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Naloxone Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Naloxone Sales by Application (2018-2024) & (K Units)
Table 38. Global Naloxone Sales by Application (2024-2029) & (K Units)
Table 39. Global Naloxone Sales Share by Application (2018-2024)
Table 40. Global Naloxone Sales Share by Application (2024-2029)
Table 41. Global Naloxone Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Naloxone Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Naloxone Revenue Share by Application (2018-2024)
Table 44. Global Naloxone Revenue Share by Application (2024-2029)
Table 45. Naloxone Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Naloxone Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Naloxone Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Naloxone Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Naloxone Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Naloxone Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Naloxone Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Naloxone Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Naloxone Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Naloxone Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Naloxone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Naloxone Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Naloxone Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Naloxone Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Naloxone Sales by Country (2024-2029) & (K Units)
Table 60. Europe Naloxone Sales by Type (2018-2024) & (K Units)
Table 61. Europe Naloxone Sales by Type (2024-2029) & (K Units)
Table 62. Europe Naloxone Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Naloxone Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Naloxone Sales by Application (2018-2024) & (K Units)
Table 65. Europe Naloxone Sales by Application (2024-2029) & (K Units)
Table 66. Europe Naloxone Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Naloxone Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Naloxone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Naloxone Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Naloxone Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Naloxone Sales by Country (2018-2024) & (K Units)
Table 72. Europe Naloxone Sales by Country (2024-2029) & (K Units)
Table 73. China Naloxone Sales by Type (2018-2024) & (K Units)
Table 74. China Naloxone Sales by Type (2024-2029) & (K Units)
Table 75. China Naloxone Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Naloxone Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Naloxone Sales by Application (2018-2024) & (K Units)
Table 78. China Naloxone Sales by Application (2024-2029) & (K Units)
Table 79. China Naloxone Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Naloxone Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Naloxone Sales by Type (2018-2024) & (K Units)
Table 82. Asia Naloxone Sales by Type (2024-2029) & (K Units)
Table 83. Asia Naloxone Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Naloxone Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Naloxone Sales by Application (2018-2024) & (K Units)
Table 86. Asia Naloxone Sales by Application (2024-2029) & (K Units)
Table 87. Asia Naloxone Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Naloxone Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Naloxone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Naloxone Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Naloxone Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Naloxone Sales by Region (2018-2024) & (K Units)
Table 93. Asia Naloxone Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Naloxone Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Naloxone Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Naloxone Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Naloxone Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Naloxone Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Naloxone Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Naloxone Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Naloxone Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Naloxone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Naloxone Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Naloxone Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Naloxone Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Naloxone Sales by Country (2024-2029) & (K Units)
Table 107. ADAPT Pharma Company Information
Table 108. ADAPT Pharma Description and Major Businesses
Table 109. ADAPT Pharma Naloxone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. ADAPT Pharma Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. ADAPT Pharma Recent Developments
Table 112. Amphastar Pharmaceuticals Company Information
Table 113. Amphastar Pharmaceuticals Description and Major Businesses
Table 114. Amphastar Pharmaceuticals Naloxone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Amphastar Pharmaceuticals Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Amphastar Pharmaceuticals Recent Developments
Table 117. Pfizer Company Information
Table 118. Pfizer Description and Major Businesses
Table 119. Pfizer Naloxone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Pfizer Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Pfizer Recent Developments
Table 122. Kaleo Company Information
Table 123. Kaleo Description and Major Businesses
Table 124. Kaleo Naloxone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Kaleo Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Kaleo Recent Developments
Table 127. Sandoz Company Information
Table 128. Sandoz Description and Major Businesses
Table 129. Sandoz Naloxone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Sandoz Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Sandoz Recent Developments
Table 132. Amneal Pharmaceuticals Company Information
Table 133. Amneal Pharmaceuticals Description and Major Businesses
Table 134. Amneal Pharmaceuticals Naloxone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Amneal Pharmaceuticals Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Amneal Pharmaceuticals Recent Developments
Table 137. West Ward Pharmaceuticals Company Information
Table 138. West Ward Pharmaceuticals Description and Major Businesses
Table 139. West Ward Pharmaceuticals Naloxone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. West Ward Pharmaceuticals Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. West Ward Pharmaceuticals Recent Developments
Table 142. Mylan Company Information
Table 143. Mylan Description and Major Businesses
Table 144. Mylan Naloxone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Mylan Naloxone Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Mylan Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Naloxone Distributors List
Table 150. Naloxone Customers List
Table 151. Naloxone Market Trends
Table 152. Naloxone Market Drivers
Table 153. Naloxone Market Challenges
Table 154. Naloxone Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Naloxone Product Picture
Figure 2. Global Naloxone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Naloxone Market Share by Type in 2022 & 2029
Figure 4. Spray Forms Product Picture
Figure 5. Injectable Forms Product Picture
Figure 6. Global Naloxone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Naloxone Market Share by Application in 2022 & 2029
Figure 8. Drug Store
Figure 9. Hospital Pharmacies
Figure 10. Online
Figure 11. Naloxone Report Years Considered
Figure 12. Global Naloxone Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Naloxone Revenue 2018-2029 (US$ Million)
Figure 14. Global Naloxone Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Naloxone Revenue Market Share by Region (2018-2029)
Figure 16. Global Naloxone Sales 2018-2029 ((K Units)
Figure 17. Global Naloxone Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Naloxone Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Naloxone Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Naloxone Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Naloxone Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Naloxone Sales YoY (2018-2029) & (K Units)
Figure 23. China Naloxone Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Naloxone Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Naloxone Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Naloxone Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Naloxone Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Naloxone Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Naloxone in the World: Market Share by Naloxone Revenue in 2022
Figure 30. Global Naloxone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Naloxone Sales Market Share by Type (2018-2029)
Figure 32. Global Naloxone Revenue Market Share by Type (2018-2029)
Figure 33. Global Naloxone Sales Market Share by Application (2018-2029)
Figure 34. Global Naloxone Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Naloxone Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Naloxone Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Naloxone Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Naloxone Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Naloxone Revenue Share by Country (2018-2029)
Figure 40. US & Canada Naloxone Sales Share by Country (2018-2029)
Figure 41. U.S. Naloxone Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Naloxone Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Naloxone Sales Market Share by Type (2018-2029)
Figure 44. Europe Naloxone Revenue Market Share by Type (2018-2029)
Figure 45. Europe Naloxone Sales Market Share by Application (2018-2029)
Figure 46. Europe Naloxone Revenue Market Share by Application (2018-2029)
Figure 47. Europe Naloxone Revenue Share by Country (2018-2029)
Figure 48. Europe Naloxone Sales Share by Country (2018-2029)
Figure 49. Germany Naloxone Revenue (2018-2029) & (US$ Million)
Figure 50. France Naloxone Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Naloxone Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Naloxone Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Naloxone Revenue (2018-2029) & (US$ Million)
Figure 54. China Naloxone Sales Market Share by Type (2018-2029)
Figure 55. China Naloxone Revenue Market Share by Type (2018-2029)
Figure 56. China Naloxone Sales Market Share by Application (2018-2029)
Figure 57. China Naloxone Revenue Market Share by Application (2018-2029)
Figure 58. Asia Naloxone Sales Market Share by Type (2018-2029)
Figure 59. Asia Naloxone Revenue Market Share by Type (2018-2029)
Figure 60. Asia Naloxone Sales Market Share by Application (2018-2029)
Figure 61. Asia Naloxone Revenue Market Share by Application (2018-2029)
Figure 62. Asia Naloxone Revenue Share by Region (2018-2029)
Figure 63. Asia Naloxone Sales Share by Region (2018-2029)
Figure 64. Japan Naloxone Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Naloxone Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Naloxone Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Naloxone Revenue (2018-2029) & (US$ Million)
Figure 68. India Naloxone Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Naloxone Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Naloxone Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Naloxone Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Naloxone Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Naloxone Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Naloxone Sales Share by Country (2018-2029)
Figure 75. Brazil Naloxone Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Naloxone Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Naloxone Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Naloxone Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Naloxone Revenue (2018-2029) & (US$ Million)
Figure 80. Naloxone Value Chain
Figure 81. Naloxone Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries